{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:34:51Z","timestamp":1792427691852,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000055","name":"National Institute on Deafness and Other Communication Disorders","doi-asserted-by":"publisher","award":["DC000082-02"],"award-info":[{"award-number":["DC000082-02"]}],"id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000055","name":"National Institute on Deafness and Other Communication Disorders","doi-asserted-by":"publisher","award":["DC000039"],"award-info":[{"award-number":["DC000039"]}],"id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Methods & Clinical Development"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.omtm.2025.101456","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T06:26:57Z","timestamp":1742624817000},"page":"101456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["AAV-mediated inner ear gene delivery triggers mild host immune responses in the mammalian inner ear"],"prefix":"10.1016","volume":"33","author":[{"given":"Yasuko","family":"Ishibashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianliang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwladys","family":"Gernoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunkai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle J.","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Isgrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mhamed","family":"Grati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafal","family":"Olszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas B.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oumeya","family":"Adjali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3865-3918","authenticated-orcid":false,"given":"Wade W.","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2025.101456_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.heares.2017.12.010","article-title":"Communication pathways to and from the inner ear and their contributions to drug delivery","volume":"362","author":"Salt","year":"2018","journal-title":"Hear. Res."},{"key":"10.1016\/j.omtm.2025.101456_bib2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","article-title":"Adeno-Associated Virus (AAV) as a Vector for Gene Therapy","volume":"31","author":"Naso","year":"2017","journal-title":"BioDrugs"},{"key":"10.1016\/j.omtm.2025.101456_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/AUD.0000000000000088","article-title":"Gene therapy for sensorineural hearing loss","volume":"36","author":"Chien","year":"2015","journal-title":"Ear Hear."},{"key":"10.1016\/j.omtm.2025.101456_bib4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2174\/1566523214666140302193709","article-title":"Basic biology of adeno-associated virus (AAV) vectors used in gene therapy","volume":"14","author":"Balakrishnan","year":"2014","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.omtm.2025.101456_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.heares.2020.107947","article-title":"Adeno-associated virus gene replacement for recessive inner ear dysfunction: Progress and challenges","volume":"394","author":"Askew","year":"2020","journal-title":"Hear. Res."},{"key":"10.1016\/j.omtm.2025.101456_bib6","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41434-020-0177-1","article-title":"Gene therapy development in hearing research in China","volume":"27","author":"Zhang","year":"2020","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2025.101456_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202306788","article-title":"AAV-Mediated Gene Therapy Restores Hearing in Patients with DFNB9 Deafness","volume":"11","author":"Qi","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.omtm.2025.101456_bib8","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/S0140-6736(23)02874-X","article-title":"AAV1-hOTOF gene therapy for autosomal recessive deafness 9: a single-arm trial","volume":"403","author":"Lv","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2025.101456_bib9","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nm1358","article-title":"Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response","volume":"12","author":"Manno","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2025.101456_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000659","article-title":"Safety and efficacy of subretinal readministration of a viral vector in large animals to treat congenital blindness","volume":"2","author":"Amado","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2025.101456_bib11","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fimmu.2015.00120","article-title":"Adeno-Associated Viral Vectors at the Frontier between Tolerance and Immunity","volume":"6","author":"Mingozzi","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2025.101456_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/blood-2013-01-306647","article-title":"Immune responses to AAV vectors: overcoming barriers to successful gene therapy","volume":"122","author":"Mingozzi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101456_bib13","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/j.ymthe.2018.07.011","article-title":"Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy","volume":"26","author":"Duan","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101456_bib14","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1089\/hum.2020.182","article-title":"Moving Forward After Two Deaths in a Gene Therapy Trial of Myotubular Myopathy","volume":"31","author":"Wilson","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2025.101456_bib15","series-title":"The Immune System","author":"Parham","year":"2021"},{"key":"10.1016\/j.omtm.2025.101456_bib16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/cr.2009.139","article-title":"Complement and its role in innate and adaptive immune responses","volume":"20","author":"Dunkelberger","year":"2010","journal-title":"Cell Res."},{"key":"10.1016\/j.omtm.2025.101456_bib17","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1146\/annurev.immunol.23.021704.115835","article-title":"Role of C5a in inflammatory responses","volume":"23","author":"Guo","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.omtm.2025.101456_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98412-y","article-title":"Refining surgical techniques for efficient posterior semicircular canal gene delivery in the adult mammalian inner ear with minimal hearing loss","volume":"11","author":"Zhu","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2025.101456_bib19","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1128\/MCB.20.11.4106-4114.2000","article-title":"Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion","volume":"20","author":"Jung","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.omtm.2025.101456_bib20","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/cne.20619","article-title":"Mononuclear phagocytes migrate into the murine cochlea after acoustic trauma","volume":"489","author":"Hirose","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.omtm.2025.101456_bib21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10162-006-0051-x","article-title":"CC chemokine receptor 2 is protective against noise-induced hair cell death: studies in CX3CR1(+\/GFP) mice","volume":"7","author":"Sautter","year":"2006","journal-title":"J. Assoc. Res. Otolaryngol."},{"key":"10.1016\/j.omtm.2025.101456_bib22","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/cne.21583","article-title":"Repopulation of cochlear macrophages in murine hematopoietic progenitor cell chimeras: the role of CX3CR1","volume":"506","author":"Sato","year":"2008","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.omtm.2025.101456_bib23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10162-009-0198-3","article-title":"Expression of fractalkine receptor CX3CR1 on cochlear macrophages influences survival of hair cells following ototoxic injury","volume":"11","author":"Sato","year":"2010","journal-title":"J. Assoc. Res. Otolaryngol."},{"key":"10.1016\/j.omtm.2025.101456_bib24","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10162-014-0458-8","article-title":"Systemic lipopolysaccharide induces cochlear inflammation and exacerbates the synergistic ototoxicity of kanamycin and furosemide","volume":"15","author":"Hirose","year":"2014","journal-title":"J. Assoc. Res. Otolaryngol."},{"key":"10.1016\/j.omtm.2025.101456_bib25","doi-asserted-by":"crossref","first-page":"15050","DOI":"10.1523\/JNEUROSCI.2325-15.2015","article-title":"Fractalkine Signaling Regulates Macrophage Recruitment into the Cochlea and Promotes the Survival of Spiral Ganglion Neurons after Selective Hair Cell Lesion","volume":"35","author":"Kaur","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.omtm.2025.101456_bib26","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fncel.2015.00150","article-title":"Macrophage recruitment and epithelial repair following hair cell injury in the mouse utricle","volume":"9","author":"Kaur","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.omtm.2025.101456_bib27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.heares.2017.04.006","article-title":"Two cell populations participate in clearance of damaged hair cells from the sensory epithelia of the inner ear","volume":"352","author":"Hirose","year":"2017","journal-title":"Hear. Res."},{"key":"10.1016\/j.omtm.2025.101456_bib28","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3389\/fnins.2019.00620","article-title":"Lack of Fractalkine Receptor on Macrophages Impairs Spontaneous Recovery of Ribbon Synapses After Moderate Noise Trauma in C57BL\/6 Mice","volume":"13","author":"Kaur","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.omtm.2025.101456_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.781702","article-title":"Distribution of Immune Cells Including Macrophages in the Human Cochlea","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.omtm.2025.101456_bib30","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/jnr.21625","article-title":"Bone marrow-derived cells expressing Iba1 are constitutively present as resident tissue macrophages in the mouse cochlea","volume":"86","author":"Okano","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.omtm.2025.101456_bib31","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1182\/blood.V81.6.1607.1607","article-title":"Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins","volume":"81","author":"Holness","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101456_bib32","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.immuni.2017.06.008","article-title":"Mechanisms and Therapeutic Relevance of Neuro-immune Communication","volume":"46","author":"Chavan","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.omtm.2025.101456_bib33","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1074\/jbc.M110.169839","article-title":"Fractalkine attenuates excito-neurotoxicity via microglial clearance of damaged neurons and antioxidant enzyme heme oxygenase-1 expression","volume":"286","author":"Noda","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omtm.2025.101456_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.694292","article-title":"Innate Immunity to Spiral Ganglion Neuron Loss: A Neuroprotective Role of Fractalkine Signaling in Injured Cochlea","volume":"15","author":"Stothert","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.omtm.2025.101456_bib35","doi-asserted-by":"crossref","DOI":"10.1177\/1759091415608204","article-title":"Disruption of Fractalkine Signaling Leads to Microglial Activation and Neuronal Damage in the Diabetic Retina","volume":"7","author":"Cardona","year":"2015","journal-title":"ASN Neuro"},{"key":"10.1016\/j.omtm.2025.101456_bib36","first-page":"303","article-title":"Fractalkine Signaling Attenuates Perivascular Clustering of Microglia and Fibrinogen Leakage during Systemic Inflammation in Mouse Models of Diabetic Retinopathy","volume":"10","author":"Mendiola","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.omtm.2025.101456_bib37","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ymthe.2006.05.009","article-title":"Adeno-associated virus serotypes: vector toolkit for human gene therapy","volume":"14","author":"Wu","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101456_bib38","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jhep.2023.10.029","article-title":"Adeno-associated viruses for gene therapy - clinical implications and liver-related complications, a guide for hepatologists","volume":"80","author":"Mucke","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.omtm.2025.101456_bib39","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1089\/hum.2017.150","article-title":"Unraveling the Complex Story of Immune Responses to AAV Vectors Trial After Trial","volume":"28","author":"Vandamme","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2025.101456_bib40","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nm1549","article-title":"CD8(+) T-cell responses to adeno-associated virus capsid in humans","volume":"13","author":"Mingozzi","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2025.101456_bib41","doi-asserted-by":"crossref","DOI":"10.1172\/JCI143780","article-title":"Overcoming innate immune barriers that impede AAV gene therapy vectors","volume":"131","author":"Muhuri","year":"2021","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtm.2025.101456_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.heares.2023.108735","article-title":"Immune responses in the mammalian inner ear and their implications for AAV-mediated inner ear gene therapy","volume":"432","author":"Ishibashi","year":"2023","journal-title":"Hear. Res."},{"key":"10.1016\/j.omtm.2025.101456_bib43","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1146\/annurev-virology-101416-041936","article-title":"Overcoming the Host Immune Response to Adeno-Associated Virus Gene Delivery Vectors: The Race Between Clearance, Tolerance, Neutralization, and Escape","volume":"4","author":"Mingozzi","year":"2017","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.omtm.2025.101456_bib44","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/S0140-6736(07)60982-9","article-title":"Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial","volume":"369","author":"Kaplitt","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2025.101456_bib45","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(09)61836-5","article-title":"Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial","volume":"374","author":"Maguire","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2025.101456_bib46","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002865","article-title":"AAV2 gene therapy readministration in three adults with congenital blindness","volume":"4","author":"Bennett","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2025.101456_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312818","article-title":"Risk Mitigation of Immunogenicity: A Key to Personalized Retinal Gene Therapy","volume":"22","author":"Varin","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtm.2025.101456_bib48","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1007\/s12035-018-1366-4","article-title":"Effects of Neutralizing Antibody Production on AAV-PHP.B-Mediated Transduction of the Mouse Central Nervous System","volume":"56","author":"Shinohara","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.omtm.2025.101456_bib49","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1089\/hum.2021.287","article-title":"Global Seroprevalence of Pre-existing Immunity Against AAV5 and Other AAV Serotypes in People with Hemophilia A","volume":"33","author":"Klamroth","year":"2022","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2025.101456_bib50","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1089\/hum.2009.182","article-title":"Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors","volume":"21","author":"Boutin","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2025.101456_bib51","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005708","article-title":"In vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous","volume":"5","author":"Dalkara","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2025.101456_bib52","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ymthe.2005.09.009","article-title":"Identification of mouse AAV capsid-specific CD8+ T cell epitopes","volume":"12","author":"Sabatino","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101456_bib53","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1016\/j.ymthe.2023.08.001","article-title":"Human cochlear diffusion from the cerebrospinal fluid space with gadolinium contrast","volume":"31","author":"Totten","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101456_bib54","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1089\/hum.2023.119","article-title":"Understanding and tackling immune responses to AAV vectors","volume":"34","author":"Costa-Verdera","year":"2023","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2025.101456_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.heares.2004.04.016","article-title":"The guide to plotting a cochleogram","volume":"197","author":"Viberg","year":"2004","journal-title":"Hear. Res."},{"key":"10.1016\/j.omtm.2025.101456_bib56","doi-asserted-by":"crossref","first-page":"977","DOI":"10.3389\/fneur.2019.00977","article-title":"Cytokine Levels in Inner Ear Fluid of Young and Aged Mice as Molecular Biomarkers of Noise-Induced Hearing Loss","volume":"10","author":"Landegger","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.omtm.2025.101456_bib57","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0378-5955(03)00137-0","article-title":"Contamination of perilymph sampled from the basal cochlear turn with cerebrospinal fluid","volume":"182","author":"Salt","year":"2003","journal-title":"Hear. Res."},{"key":"10.1016\/j.omtm.2025.101456_bib58","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1158\/1055-9965.EPI-18-0598","article-title":"Relationship between Circulating Inflammation Proteins and Lung Cancer Diagnosis in the National Lung Screening Trial","volume":"28","author":"Brown","year":"2019","journal-title":"Cancer Epidemiol. Biomarkers Prev."}],"container-title":["Molecular Therapy Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125000518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125000518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:55:09Z","timestamp":1778867709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050125000518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2329050125000518"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101456","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AAV-mediated inner ear gene delivery triggers mild host immune responses in the mammalian inner ear","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101456","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"101456"}}